DISCONTINUED OPERATIONS (Details) - Discontinued Operations, Disposed of by Sale - RX Pharmaceuticals $ in Millions |
Jun. 28, 2025
USD ($)
|
---|---|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent) | 50.00% |
Aggregate cap on buyer's obligation for certain pre-closing liabilities | $ 50.0 |
Estimated litigation liability, current | $ 30.0 |
X | ||||||||||
- Definition Disposal Group, Including Discontinued Operation, Indemnification Asset No definition available.
|
X | ||||||||||
- Definition Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|